Komljenovic D - Search Results

1

Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.

Bäuerle T, Komljenovic D, Berger MR, Semmler W. Bäuerle T, et al. Among authors: komljenovic d. J Vis Exp. 2012 Aug 14;(66):e4178. doi: 10.3791/4178. J Vis Exp. 2012. PMID: 22929330 Free PMC article.

2

Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study.

Bäuerle T, Merz M, Komljenovic D, Zwick S, Semmler W. Bäuerle T, et al. Among authors: komljenovic d. Clin Cancer Res. 2010 Jun 15;16(12):3215-25. doi: 10.1158/1078-0432.CCR-09-2932. Epub 2010 Jun 8. Clin Cancer Res. 2010. PMID: 20530698

3

Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.

Bäuerle T, Komljenovic D, Merz M, Berger MR, Goodman SL, Semmler W. Bäuerle T, et al. Among authors: komljenovic d. Int J Cancer. 2011 May 15;128(10):2453-62. doi: 10.1002/ijc.25563. Int J Cancer. 2011. PMID: 20648558

4

Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases.

Merz M, Komljenovic D, Zwick S, Semmler W, Bäuerle T. Merz M, et al. Among authors: komljenovic d. Eur J Cancer. 2011 Jan;47(2):277-86. doi: 10.1016/j.ejca.2010.08.019. Epub 2010 Sep 20. Eur J Cancer. 2011. PMID: 20863686

5

Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG.

Cheng C, Komljenovic D, Pan L, Dimitrakopoulou-Strauss A, Strauss L, Bäuerle T. Cheng C, et al. Among authors: komljenovic d. Hell J Nucl Med. 2011 Jan-Apr;14(1):15-20. Hell J Nucl Med. 2011. PMID: 21512659

6

Cilengitide inhibits metastatic bone colonization in a nude rat model.

Bretschi M, Merz M, Komljenovic D, Berger MR, Semmler W, Bäuerle T. Bretschi M, et al. Among authors: komljenovic d. Oncol Rep. 2011 Oct;26(4):843-51. doi: 10.3892/or.2011.1373. Epub 2011 Jul 1. Oncol Rep. 2011. PMID: 21725616

7

A novel PET tracer for the imaging of αvβ3 and αvβ5 integrins in experimental breast cancer bone metastases.

Mühlhausen U, Komljenovic D, Bretschi M, Leotta K, Eisenhut M, Semmler W, Bäuerle T. Mühlhausen U, et al. Among authors: komljenovic d. Contrast Media Mol Imaging. 2011 Nov-Dec;6(6):413-20. doi: 10.1002/cmmi.435. Contrast Media Mol Imaging. 2011. PMID: 22162137 Free article.

8

Monitoring molecular, functional and morphologic aspects of bone metastases using non-invasive imaging.

Bauerle T, Komljenovic D, Semmler W. Bauerle T, et al. Among authors: komljenovic d. Curr Pharm Biotechnol. 2012 Mar;13(4):584-94. doi: 10.2174/138920112799436285. Curr Pharm Biotechnol. 2012. PMID: 22214500 Review.

9

Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.

Merz M, Komljenovic D, Semmler W, Bäuerle T. Merz M, et al. Among authors: komljenovic d. Invest Radiol. 2012 Jul;47(7):422-9. doi: 10.1097/RLI.0b013e31824f635a. Invest Radiol. 2012. PMID: 22659593

10

Loss of stromal JUNB does not affect tumor growth and angiogenesis.

Braun J, Strittmatter K, Nübel T, Komljenovic D, Sator-Schmitt M, Bäuerle T, Angel P, Schorpp-Kistner M. Braun J, et al. Among authors: komljenovic d. Int J Cancer. 2014 Mar 15;134(6):1511-6. doi: 10.1002/ijc.28477. Epub 2013 Oct 9. Int J Cancer. 2014. PMID: 24027048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters